Neoantigen Targeting Market to Exceed $12.4 Billion by 2032 with 21.6% CAGR Growth
The global Neoantigen Targeting market is experiencing rapid expansion due to increasing investments in personalized cancer immunotherapy and precision medicine. In 2023, the market was valued at approximately USD 2.15 billion, reflecting a 19.4% increase from USD 1.8 billion in 2022. More than 67% of oncology research institutions are now focusing on Neoantigen Targeting technologies, driven by See More rising cancer incidence and the growing success of individualized therapeutic approaches.
Read Full Research Study: https://marketintelo.com/report/neoantigen-targeting-market
The global Neoantigen Targeting market is experiencing rapid expansion due to increasing investments in personalized cancer immunotherapy and precision medicine. In 2023, the market was valued at approximately USD 2.15 billion, reflecting a 19.4% increase from USD 1.8 billion in 2022. More than 67% of oncology research institutions are now focusing on Neoantigen Targeting technologies, driven by See More rising cancer incidence and the growing success of individualized therapeutic approaches.
Read Full Research Study: https://marketintelo.com/report/neoantigen-targeting-market
on Thursday